3 Healthcare Stocks With Long Growth Runways

Three healthcare stocks with long growth runways could lift the sector to greater heights in 2023 and beyond.

| More on:
A doctor takes a patient's blood pressure in a clinical office.

Source: Getty Images

The healthcare sector has performed poorly in recent years, including the COVID year in 2020. Surprisingly, as of this writing, it outperforms all sectors with its 11.95% year-to-date gain.

A reversal of fortune might be on the horizon, especially for growth stocks like Bausch Health Companies (TSX:BHC), Andlauer Healthcare Group (TSX:AND), and Neighbourly Pharmacy (TSX:NBLY).

Extensive product pipeline

Bausch Health develops, manufactures, and markets a range of products in dermatology, gastroenterology, hepatology, neurology, and international pharmaceuticals. It offers a broad range of branded and generic pharmaceuticals, including over-the-counter (OTC) products. Moreover, the global reach extends from North America to several geographic regions.

Current investors delight in the stock’s strong start in 2023 and the 19.53% advance to $10.06 from year-end 2022. Market analysts’ high price target in 12 months is $18.76 — an 86.5% return potential.

The $3.67 billion diversified pharmaceutical company derives health revenues from five segments. According to management, the product pipeline and portfolio expansion reflect Bausch’s commitment to developing innovative products that can help improve people’s lives.

Specialized services

Andlauer Healthcare Group, or AHG, flies under the radar, but it deserves attention following the impressive financial results after three quarters in 2022. Also, at $47.20 per share (-0.32% year to date), this healthcare stock pays a modest 0.59% dividend. Based on market analysts’ forecasts, the price could climb to as high as $60 in 12 months.

In the nine months that ended September 30, 2022, total revenue and net income jumped 57.2% and 53.2% year over year to $482.65 million and $56.45 million, respectively. The top- and bottom-line growth in the third quarter of 2022 were 58.3% and 55.9%. Notably, ground transportation reported the most significant percentage increases in revenue and income.

Its chief executive officer (CEO) Michael Andlauer said, “Our strong growth in revenue and profitability in the quarter and year-to-date reflects the significant impact of our recent acquisitions in both our healthcare logistics and specialized transportation segments.” The full-year 2022 results will come soon, although Andlauer expects to report solid earnings momentum and a strong balance sheet.

AHG takes pride in its robust platform of customized third-party logistics and specialized transportation solutions for the healthcare sector. The $1.97 billion growth-oriented supply chain management company plans to seize further opportunities to expand its North American platform and build value for stakeholders.

Healthcare first

Neighbourly Pharmacy is about community pharmacies and a “healthcare first” strategy that drives performance. The $1.03 billion company desires to be the leader in community healthcare and is on track to achieve that objective. It’s now Canada’s largest and fastest-growing network of independent pharmacies.

Management entered into two binding agreements in October 2022 to acquire eight community pharmacies. The locations of the pharmacies are primarily in smaller, underserved markets, favouring Neighbourly. Apart from generating the bulk of revenues from prescription sales, the competition is less intense.

Neighbourly is also a dividend payer. At $23.30 per share (-0.38% year to date), the dividend yield is 0.77%.

Long growth runways

Bausch Health, Andlauer Healthcare, and Neighbourly Pharmacy have one common denominator: a long growth runway. The companies have catalysts that should propel their stock prices higher in the near term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Andlauer Healthcare Group. The Motley Fool has a disclosure policy.

More on Dividend Stocks

dividend stocks are a good way to earn passive income
Dividend Stocks

This 4.2% Monthly Payer Is the Income Investor’s Dream Stock

Are you looking for a growing stream of monthly dividends and strong capital returns ahead? This Canadian stock could be…

Read more »

happy woman throws cash
Dividend Stocks

I’m Going All-In Because This Stock Never Lets Me Down

Given its solid financial performance, consistent returns, and high growth prospects, this Canadian stock is ideal for long-term investors.

Read more »

dividend growth for passive income
Dividend Stocks

I’d Put My Entire TFSA Into This 7 Percent Monthly-Paying Dividend Stock

Here's why TFSA investors should consider gaining exposure to this high-yield monthly dividend stock right now.

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

A 7.6% Dividend Stock Paying Cash Every Single Month

Whitecap's mesmerizing dividend is safe for now, but what would it take for it to cut it?

Read more »

Concept of rent, search, purchase real estate, REIT
Dividend Stocks

A Perfect 7.9% Dividend Stock Paying Out Cash Every Single Month

If you're looking for cash immediately, this stock certainly is one to watch.

Read more »

Hourglass projecting a dollar sign as shadow
Dividend Stocks

The 4.2% Monthly Payer That Could Fund Your Retirement

This TSX-listed holding company pays monthly dividends and is unlike any other.

Read more »

dividends can compound over time
Dividend Stocks

Contrarian Investors: 1 Discounted TSX Dividend Stock to Consider Now

The top Canadian dividend-growth stock might be oversold right now.

Read more »

Piggy bank on a flying rocket
Dividend Stocks

The 4% Monthly Dividend That Beats Any Savings Account

Want an investment that can beat any savings account? This monthly dividend payer boasts high yields and stellar growth potential.

Read more »